Distinguished Research Scientist, Autodesk Inc., Faculty, Singularity UniversityBiography
Autodesk Distinguished Research Andrew Hessel excels at building bridges and catalyzing change. He is a trend-spotter in life science and helps individuals and organizations better understand and prepare for a future of accelerating innovation. He is also the co-founder of the Pink Army Cooperative, the world's first cooperative biotechnology company, which is aiming to produce open source viral therapies for cancer. Trained in microbiology and genetics, Andrew has continually worked at the forefront of genomics, first to read and comprehend bacterial, human, and other genomes and more recently to write them. He believes the technology that makes this possible, know as synthetic biology, is revolutionary and that it will eventually surpass information technology (IT) as an economic engine and driver of societal change. He is an advocate of open source genetic engineering and sees DNA technologies growing to resemble the software industry as they continue to evolve. He speaks widely on topics that include cells as living computers, life science as an emerging digital industry, and biological safety and security.